News | February 01, 2024
Zydus Lifesciences launches Rexigo
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Combines biocompatibility, heat-resistance, transparency and durability
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
The new campus has been designed as an employee-centred experience and ecosystem zone
Gabapentin is indicated for the management of Postherpetic Neuraligia
The registered capital of the newly founded company is € 50 million
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Subscribe To Our Newsletter & Stay Updated
